Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 82c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.39 --0%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.39), $0.82 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $62.5 million versus the consensus estimate of $172.97 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- RBC Capital Resumes BorgWarner (BWA) at Outperform
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
